Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

NCT02381015 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT02381015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
Lead sponsor
Endeavor Health
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
700 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary prostate cancer, prostate cancer, prostate cancer, familial